Compare AWX & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AWX | BFRI |
|---|---|---|
| Founded | 1998 | 1997 |
| Country | United States | United States |
| Employees | N/A | 94 |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 9.5M |
| IPO Year | 1998 | N/A |
| Metric | AWX | BFRI |
|---|---|---|
| Price | $2.59 | $0.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 3.5K | ★ 94.9K |
| Earning Date | 03-19-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $53,090,000.00 | N/A |
| Revenue This Year | N/A | $11.67 |
| Revenue Next Year | N/A | $19.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.14 | N/A |
| 52 Week Low | $2.10 | $0.54 |
| 52 Week High | $5.43 | $1.18 |
| Indicator | AWX | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 48.96 | 39.02 |
| Support Level | $2.56 | $0.71 |
| Resistance Level | $2.60 | $0.89 |
| Average True Range (ATR) | 0.03 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 53.33 | 19.09 |
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.